Visit us at booth #30

May 2, 2017 12:15 Luncheon Presentation: Simoa for the Ultra-Sensitive Measurement of Proteins as Biomarkers of Immuno-Oncology Therapeutics

Mark Roskey, Ph.D., Vice President and General Manager, Quanterix

We will describe the use of single molecule arrays (Simoa) to measure proteins that are emerging as important biomarkers for the effectiveness of immuno-oncology therapies. Immune-targeted therapies, e.g., checkpoint inhibitors, have emerged as the next generation approaches to treating cancer.

Register for the meeting here